Skip to content

Weka Investing

Weka Investing with Curiosity

Menu

  • Home
  • Newsletters
  • About us
  • Dividends

GARP

You are here: Home » GARP

Dividend Aristocrats – A good choice for dividend investors

person using phone and laptop computer

Investing in dividend aristocrat stocks can be a smart decision for those looking to increase the passive income potential of their investments. Dividend aristocrat stocks, or companies that have increased their dividend payments for 25 consecutive years, have historically outperformed

lwoo034 December 23, 2022December 23, 2022 Dividend Investing, GARP Read more

Novartis (NVS) – pharmaceutical GARP

assorted-color pills

In today’s unpredictable market, it is becoming increasingly difficult for investors to find stocks that can deliver consistent, long-term growth at a reasonable price (GARP). Pharmaceutical stocks can be an excellent option for investors looking for growth opportunities without paying

lwoo034 December 12, 2022 Dividend Investing, GARP Read more

Growth at a reasonable price (GARP) for dividend investors

TD as a GARP stock

Investing in equities with high dividend yields can be a great way to maximize returns in the long run. However, dividend investors must know the risks associated with chasing yield and the potential for lower returns when certain companies are

lwoo034 December 12, 2022December 12, 2022 Dividend Investing, GARP Read more

Recent Posts

  • Dividend Aristocrats – A good choice for dividend investors
  • Are my BDC dividends safe?
  • Novartis (NVS) – pharmaceutical GARP
  • Growth at a reasonable price (GARP) for dividend investors
  • Proctor and Gamble (PG) – the undisputed Dividend King!

Recent Comments

No comments to show.

Archives

  • December 2022
  • November 2022

Categories

  • Dividend Investing
  • GARP
  • Income Investing
  • Investing Strategy
  • REIT
Copyright © 2023 Weka Investing. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.
  • Home
  • Newsletters
  • About us
  • Dividends